Evaluation of the Antimicrobial Resistance Pattern of Nosocomial Infections in Patients Hospitalized in Chamran Heart Educational, Medical, and Research Center of Isfahan.

IF 0.8 Q4 PHARMACOLOGY & PHARMACY
Journal of Research in Pharmacy Practice Pub Date : 2024-08-08 eCollection Date: 2023-10-01 DOI:10.4103/jrpp.jrpp_25_24
Mehrnoush Dianatkhah, Zeinab Sadat Davoodi, Rasool Soltani, Fatemeh Shafiee, Alireza Hosseini
{"title":"Evaluation of the Antimicrobial Resistance Pattern of Nosocomial Infections in Patients Hospitalized in Chamran Heart Educational, Medical, and Research Center of Isfahan.","authors":"Mehrnoush Dianatkhah, Zeinab Sadat Davoodi, Rasool Soltani, Fatemeh Shafiee, Alireza Hosseini","doi":"10.4103/jrpp.jrpp_25_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>According to the importance of evaluating the antimicrobial resistance pattern in the management of nosocomial infections (NIs), we decided to investigate the prevalence of antimicrobial resistance in Chamran Heart Hospital.</p><p><strong>Methods: </strong>This retrospective cross-sectional observational study was performed for 6 months from February to July 2022 at Shahid Chamran Hospital of Isfahan, Iran. All hospitalized patients with any NIs were eligible for the study. Clinical specimens were obtained from patients with NIs. All specimens underwent microbial culture, and if bacterial growth developed, differential tests were performed. Antibiotic susceptibility testing also was performed per the standards of Clinical and Laboratory Standards Institute, 2022.</p><p><strong>Findings: </strong>Out of 201 examined samples, urinary infection (34.83%), pneumonia (27.86%), and sepsis (13.43%) were reported to be the most prevalent infections. Among Gram-negatives (76.12%), <i>Citrobacter</i> spp. (26.37%), <i>Escherichia coli</i> (24.87%), and <i>Klebsiella</i> spp. (11.44%) were the most common pathogens. About 54.9% of <i>Citrobacter</i> spp., 33.3% of <i>E</i>. <i>coli</i>, and 45.45% of <i>Klebsiella</i> spp. were resistant to carbapenems. About 1.88% and 15% of <i>Citrobacter</i> spp. were identified as pan-drug-resistant bacteria and extensively drug-resistant (XDR), respectively. In addition, 4.34% of <i>Klebsiella</i> spp. were identified as XDR. Among Gram-positives (23.88%), <i>Enterococcus</i> spp. (8.95%) was identified as the most common pathogen, and the prevalence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) and vancomycin-resistant <i>Enterococcus</i> (VRE) was 11.11% and 61.11%, respectively.</p><p><strong>Conclusion: </strong>In our study, carbapenem-resistant Enterobacteriaceae accounts for about 50% of all NIs. Moreover, despite the low prevalence of MRSA, VRE was reported to be high in our center when compared with other studies.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 4","pages":"135-140"},"PeriodicalIF":0.8000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11386061/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Research in Pharmacy Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jrpp.jrpp_25_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: According to the importance of evaluating the antimicrobial resistance pattern in the management of nosocomial infections (NIs), we decided to investigate the prevalence of antimicrobial resistance in Chamran Heart Hospital.

Methods: This retrospective cross-sectional observational study was performed for 6 months from February to July 2022 at Shahid Chamran Hospital of Isfahan, Iran. All hospitalized patients with any NIs were eligible for the study. Clinical specimens were obtained from patients with NIs. All specimens underwent microbial culture, and if bacterial growth developed, differential tests were performed. Antibiotic susceptibility testing also was performed per the standards of Clinical and Laboratory Standards Institute, 2022.

Findings: Out of 201 examined samples, urinary infection (34.83%), pneumonia (27.86%), and sepsis (13.43%) were reported to be the most prevalent infections. Among Gram-negatives (76.12%), Citrobacter spp. (26.37%), Escherichia coli (24.87%), and Klebsiella spp. (11.44%) were the most common pathogens. About 54.9% of Citrobacter spp., 33.3% of E. coli, and 45.45% of Klebsiella spp. were resistant to carbapenems. About 1.88% and 15% of Citrobacter spp. were identified as pan-drug-resistant bacteria and extensively drug-resistant (XDR), respectively. In addition, 4.34% of Klebsiella spp. were identified as XDR. Among Gram-positives (23.88%), Enterococcus spp. (8.95%) was identified as the most common pathogen, and the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) was 11.11% and 61.11%, respectively.

Conclusion: In our study, carbapenem-resistant Enterobacteriaceae accounts for about 50% of all NIs. Moreover, despite the low prevalence of MRSA, VRE was reported to be high in our center when compared with other studies.

伊斯法罕占兰心脏教育、医疗和研究中心住院病人非社会性感染的抗菌素耐药性模式评估。
目的鉴于评估抗菌素耐药性模式在管理院内感染(NIs)中的重要性,我们决定调查 Chamran 心脏医院的抗菌素耐药性流行情况:这项回顾性横断面观察研究于 2022 年 2 月至 7 月在伊朗伊斯法罕的 Shahid Chamran 医院进行,为期 6 个月。所有患有任何 NI 的住院患者均符合研究条件。临床标本取自患有 NIs 的患者。所有标本均进行微生物培养,如果出现细菌生长,则进行鉴别试验。此外,还根据 2022 年临床和实验室标准研究所的标准进行了抗生素药敏试验:在 201 份受检样本中,泌尿系统感染(34.83%)、肺炎(27.86%)和败血症(13.43%)是最常见的感染。在革兰氏阴性菌(76.12%)中,柠檬酸杆菌属(26.37%)、大肠埃希菌(24.87%)和克雷伯菌属(11.44%)是最常见的病原体。约 54.9% 的柠檬酸杆菌属、33.3% 的大肠埃希菌属和 45.45% 的克雷伯氏菌属对碳青霉烯类产生耐药性。约 1.88%和 15%的柠檬酸杆菌属分别被鉴定为泛耐药菌和广泛耐药菌(XDR)。此外,4.34%的克雷伯氏菌被鉴定为 XDR。在革兰氏阳性菌(23.88%)中,肠球菌属(8.95%)是最常见的病原体,耐甲氧西林金黄色葡萄球菌(MRSA)和耐万古霉素肠球菌(VRE)的感染率分别为 11.11% 和 61.11%:在我们的研究中,耐碳青霉烯类肠杆菌科细菌约占所有 NI 的 50%。此外,尽管 MRSA 感染率较低,但与其他研究相比,本中心的 VRE 感染率较高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Research in Pharmacy Practice
Journal of Research in Pharmacy Practice PHARMACOLOGY & PHARMACY-
自引率
0.00%
发文量
8
审稿时长
21 weeks
期刊介绍: The main focus of the journal will be on evidence-based drug-related medical researches (with clinical pharmacists’ intervention or documentation), particularly in the Eastern Mediterranean region. However, a wide range of closely related issues will be also covered. These will include clinical studies in the field of pharmaceutical care, reporting adverse drug reactions and human medical toxicology, pharmaco-epidemiology and toxico-epidemiology (poisoning epidemiology), social aspects of pharmacy practice, pharmacy education and economic evaluations of treatment protocols (e.g. cost-effectiveness studies). Local reports of medication utilization studies at hospital or pharmacy levels will only be considered for peer-review process only if they have a new and useful message for the international pharmacy practice professionals and readers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信